Cargando…

Jeopardized Myocardium Defined by Late Gadolinium Enhancement Magnetic Resonance Imaging Predicts Survival in Patients With Ischemic Cardiomyopathy: Impact of Revascularization

BACKGROUND: The prognostic impact of jeopardized myocardium (JM) in patients with advanced ischemic cardiomyopathy (ICM) is unclear. We hypothesized that JM is an independent predictor of mortality in patients with advanced ICM. METHODS AND RESULTS: Patients with ICM who underwent cardiac magnetic r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Deborah H., Obuchowski, Nancy A., Marwick, Thomas H., Menon, Venu, Griffin, Brian, Flamm, Scott D., Hachamovitch, Rory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404459/ https://www.ncbi.nlm.nih.gov/pubmed/30571486 http://dx.doi.org/10.1161/JAHA.118.009394

Ejemplares similares

End systolic volume and scar burden are incremental and independent predictors of survival in patients with severe ischemic cardiomyopathy
por: Kwon, Deborah, et al.
Publicado: (2012)

Impact of right ventricular end systolic volume and mitral regurgitation on survival in patients with severe ischemic cardiomyopathy
por: Kwon, Deborah, et al.
Publicado: (2013)

Right ventricular volumes vs. right ventricular ejection fraction are more powerful independent predictors of survival in patients with severe ischemic cardiomyopathy
por: Nazir, Noreen, et al.
Publicado: (2012)

Right ventricular systolic dysfunction in patients with severe ischemic cardiomyopathy - CMR insights into an interventricular relationship
por: Cavalcante, Joao L, et al.
Publicado: (2013)

Going beyond ejection fraction - CMR assessment of ventricular-vascular coupling and LV remodeling predicts diastolic dysfunction in advanced ischemic cardiomyopathy
por: Cavalcante, Joao L, et al.
Publicado: (2013)

Automated myocardium segmentation in late gadolinium enhanced MR images
por: Tao, Qian, et al.
Publicado: (2014)

Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender
por: Kwon, Deborah H, et al.
Publicado: (2014)

Predictors of Mortality in Patients With Severe Ischemic Cardiomyopathy Undergoing Surgical Mitral Valve Intervention
por: Kusunose, Kenya, et al.
Publicado: (2017)

Understanding why edema in salvaged myocardium is difficult to detect by late gadolinium enhancement
por: Ugander, Martin, et al.
Publicado: (2012)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

Differential Expression of microRNAs in Hypertrophied Myocardium and Their Relationship to Late Gadolinium Enhancement, Left Ventricular Hypertrophy and Remodeling in Hypertrophic Cardiomyopathy
por: Zhang, Chen, et al.
Publicado: (2022)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Late Gadolinium Enhancement of the right ventricular myocardium: Is it really different from the left ?
por: Grosse-Wortmann, Lars, et al.
Publicado: (2008)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
por: Behera, Dibya Ranjan, et al.
Publicado: (2020)

Physician preferences for revascularization in patients with ischemic cardiomyopathy: Defining equipoise from web-based surveys
por: Mukhopadhyay, Amrita, et al.
Publicado: (2023)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
por: Aquaro, Giovanni Donato, et al.
Publicado: (2023)

Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy
por: Stirrat, John, et al.
Publicado: (2015)

The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Revnic, Radu, et al.
Publicado: (2022)

CMR - Late gadolinium enhancement characteristics associated with monomorphic ventricular arrhythmia in patients with non-ischemic cardiomyopathy
por: Rajinthan, Priyanka, et al.
Publicado: (2022)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
por: Brendel, Jan M., et al.
Publicado: (2023)

Improved Quantification of Myocardium Scar in Late Gadolinium Enhancement Images: Deep Learning Based Image Fusion Approach
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2017)

Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
por: Liga, Riccardo, et al.
Publicado: (2023)

Extracellular volume-guided late gadolinium enhancement analysis for non-ischemic cardiomyopathy: The Women’s Interagency HIV Study
por: Kato, Yoko, et al.
Publicado: (2021)

Overlapping Phenotypes and Degree of Ventricular Dilatation Are Associated with Severity of Systolic Impairment and Late Gadolinium Enhancement in Non-Ischemic Cardiomyopathies
por: Boban, Marko, et al.
Publicado: (2018)

The multiplicity of analysis strategies jeopardizes replicability: lessons learned across disciplines
por: Hoffmann, Sabine, et al.
Publicado: (2021)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
por: Smith, Brandon M, et al.
Publicado: (2013)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

In/opposed phase imaging effectively differentiates fat from enhanced myocardium in patients with myocardial late gadolinium enhancement
por: Kleindienst, Denise, et al.
Publicado: (2009)

How microbes “jeopardize” the modern synthesis
por: Novick, Aaron, et al.
Publicado: (2019)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2016)

Smoking aggravates ventricular arrhythmic events in non-ischemic dilated cardiomyopathy associated with a late gadolinium enhancement in cardiac MRI
por: Park, Junbeom, et al.
Publicado: (2018)

Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non‐ischemic cardiomyopathy
por: Ota, Shingo, et al.
Publicado: (2021)

Association of Whole-Heart Myocardial Mechanics by Transthoracic Echocardiography with Presence of Late Gadolinium Enhancement by CMR in Non-Ischemic Dilated Cardiomyopathy
por: Mėlinytė-Ankudavičė, Karolina, et al.
Publicado: (2022)

Impact of late gadolinium enhancement extent, location, and pattern on ventricular tachycardia and major adverse cardiac events in patients with ischemic vs. non-ischemic cardiomyopathy
por: Tat, Emily, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5d368ldaiknu8nnjs6pum6lf7v